The arguments now being aired in the literature about the use of CK, CK-MB, etc., plus various manipulations of that data are fascinating. The paper by Vijan e t a / . ' addresses this subject, but adds little to solving the problems arising from the need for swift diagnosis of acute myocardial infarction. Is it really necessary to perform the 'slope' measurements when the first value of CK on admission in most of their 'problem' cases makes such a manoeuvre rather academic? Is it also reasonable to disregard the sample timings stipulated by Collinson et aL2 when producing a paper that questions their findings?
I also read the article by Leung et a/.3 with considerable interest but with mounting confusion. They have, perhaps unnecessarily, introduced the term 'odds' into the analysis in the Appendix, unfortunately with a definition that might partly be at odds with a majority interpretation as it only allows odds to be 'odds on'. They also have used the fashionable 'confidence intervals' for the areas under the ROC curves. There appears at first glance to be at least two sources of error for the measurement of the area under the ROC curve. First, the difference between the curves drawn from the data and the best curve that might be drawn from that data, a measure of the bias introduced by the curve drawing algorithm used. The second is the difference between the sample curve and the population curve. It would have been valuable if the paper had provided the derivation of the error estimate and the significance of the area under, or the first integral of, a ROC curve.
The course started by Vecchio4 and Galen and Gambino5 of popularizing analyses based on Bayes' theorem in clinical medicine, specially clinical biochemistry, is ripe for some definitive statement from the scientific literature limiting its use. Likelihood ratios6 use more of the data but they are thus more complex. Perhaps a set of basic, useful and allowable terms should be agreed as the twists and turns wreaked upon Bayes' theorem in the name of method evaluation and comparison in this paper and many others smack of casuistry.
It seems sensible to assume that to collect three or more data points in a structured sequence soon after admission to the CCU2 will result in more information than a single data point, although occasionally one might well do. However, the information that is obtained in 
Author's reply
In reply to Dr Chandler's letter, our short report was written in response to papers suggesting that the CK 'slope' reliably predicts acute myocardial infarction (AMI). We confirmed the predictive value of a 'positive' result, but drew attention to its clinical inadequacy. The laboratory strategy must also permit the rapid exclusion of AMI-the slope value cannot be used for that purpose (PV of a negative result=0.87). Our strategy! based on two CK measurements, with CKMB as a second line test in a minority of patients, allows the rapid confirmation or exclusion of AM1 (sensitivity = 100V0, PV of a negative result = 1 *O).
We disagree that a single high CK on admission may be used to make the diagnosis because there are too many other causes of raised CK.
The ECG permits the rapid diagnosis of AM1 and this is usually used to make the decision to give thrombolytic therapy. However, the increasing use of thrombolytic therapy-and the need to 
The old lady that lives down the street from Dr Chandler will probably, sometime during her golden years, fall and fracture her hip. If she uses long-acting barbiturates, because she does not sleep well since the recent death of her husband, she has an increased risk of falling compared to her previous state. That increased risk is described in terms of the odds ratio and is 5:2.' So she is five-times more likely now to fall and fracture her hip, than before her husband's death. However, all such measurements are subject to error, the 95% error range of the odds ratio is now actually from 0.6 to 45. We merely mention this study because it illustrates the fact that today we have to learn newer and better ways of assessing relationships between variables, and odds ratios and confidence limits are markedly superior to earlier usages. We claim no originality in our use of these techniques, we did give the sources for our approach in an earlier publication,' but we do believe that clinical chemists must learn to use them if they are to deliver an economic and appropriate service to their patients. All of the terms used are MeSH (medical subject headings) terms and can be searched in MEDLINE to obtain relevant articles for further enlightenment. The fact that they are MeSH terms at all indicates their growing significance in the medical literature. Alkaline phosphatase and rickets in the premature infant I read with interest the excellent review by Mayne and Kovar,' but would like to draw attention to two misquotations of our paper on alkaline phosphatase isoenzymes in infants.' First, all the preterm infants in our study received formula milk feeds (although two babies also received some breast milk in addition to formula); we were therefore unable to comment on the behaviour of fetal intestinal isoenzyme in exclusively breast-fed infants. Secondly, we found that in very preterm infants, the fetal intestinal isoenzyme may comprise up to 50% of total alkaline phosphatase activity by the third postnatal week, not 10% as stated by the authors. This obviously has important implications for the interpretation of increased alkaline phosphatase activities in the first month of postnatal life, and may limit the ability of total alkaline phosphatase activity to provide a reliable early prediction of rickets in the very preterm infants who are most at risk. However, I would agree with Mayne and Kovar that, by the end of the sixth postnatal week, when clinical rickets may begin to appear, the fetal intestinal isoenzyme
